2026-03-08 04:27:47


Trends:
entertainment world cricket science education business sports india

Menu
When cost stops being the barrier: The new chapter of Ozempic injection in India

The upcoming patent expiry for Ozempic in India is set to dramatically lower the cost of semaglutide, making this once-premium diabetes and weight-loss drug accessible to more patients. This shift could reshape the market, prompting earlier prescriptions and potentially altering societal views on weight management and body acceptance.

Recent Post